{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:45:00Z","timestamp":1792424700026,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2369-15-71","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T22:32:14Z","timestamp":1399329134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Pablo","family":"Ure\u00f1a-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Pri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Keddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Brian","family":"Copley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,5]]},"reference":[{"key":"765_CR1","doi-asserted-by":"publisher","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","volume":"289","author":"TJ Berndt","year":"2005","unstructured":"Berndt TJ, Schiavi S, Kumar R: \u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol. 2005, 289: F1170-F1182. 10.1152\/ajprenal.00072.2005.","journal-title":"Am J Physiol Renal Physiol"},{"key":"765_CR2","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, Kuen E, Konig P, Kraatz G, Mann JF, Muller GA, Kohler H, Riegler P: Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol. 2007, 18: 2600-2608. 10.1681\/ASN.2006080936.","journal-title":"J Am Soc Nephrol"},{"key":"765_CR3","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00198-006-0154-6","volume":"17","author":"M Inaba","year":"2006","unstructured":"Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y: Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int. 2006, 17: 1506-1513. 10.1007\/s00198-006-0154-6.","journal-title":"Osteoporos Int"},{"key":"765_CR4","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, DeFilippi C, Wolf M: Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009, 119: 2545-2552. 10.1161\/CIRCULATIONAHA.108.844506.","journal-title":"Circulation"},{"key":"765_CR5","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2215\/CJN.02740311","volume":"6","author":"OM Gutierrez","year":"2011","unstructured":"Gutierrez OM, Wolf M, Taylor EN: Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol. 2011, 6: 2871-2878. 10.2215\/CJN.02740311.","journal-title":"Clin J Am Soc Nephrol"},{"key":"765_CR6","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2010121224","volume":"22","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011, 22: 1913-1922. 10.1681\/ASN.2010121224.","journal-title":"J Am Soc Nephrol"},{"key":"765_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","volume":"26","author":"A Kirkpantur","year":"2011","unstructured":"Kirkpantur A, Balci M, Gurbuz OA, Afsar B, Canbakan B, Akdemir R, Ayli MD: Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant. 2011, 26: 1346-1354. 10.1093\/ndt\/gfq539.","journal-title":"Nephrol Dial Transplant"},{"key":"765_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","volume":"60","author":"JH Ix","year":"2012","unstructured":"Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG: Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol. 2012, 60: 200-207. 10.1016\/j.jacc.2012.03.040.","journal-title":"J Am Coll Cardiol"},{"key":"765_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000243050","volume":"32","author":"M Peiskerova","year":"2009","unstructured":"Peiskerova M, Kalousova M, Kratochvilova M, Dusilova-Sulkova S, Uhrova J, Bandur S, Malbohan IM, Zima T, Tesar V: Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?. Kidney Blood Press Res. 2009, 32: 276-283. 10.1159\/000243050.","journal-title":"Kidney Blood Press Res"},{"key":"765_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"O Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez O, Mannstadt M, Isakova T, Rauh-Hain J, Tamez H, Shah A, Smith K, Lee H, Thadhani R, J\u00fcppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008, 359: 584-592. 10.1056\/NEJMoa0706130.","journal-title":"N Engl J Med"},{"key":"765_CR11","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutierrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011, 305: 2432-2439. 10.1001\/jama.2011.826.","journal-title":"JAMA"},{"key":"765_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2215\/CJN.09570912","volume":"8","author":"J Arnlov","year":"2013","unstructured":"Arnlov J, Carlsson AC, Sundstrom J, Ingelsson E, Larsson A, Lind L, Larsson TE: Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology. Clin J Am Soc Nephrol. 2013, 8: 781-786. 10.2215\/CJN.09570912.","journal-title":"Clin J Am Soc Nephrol"},{"key":"765_CR13","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, et al: FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011, 121: 4393-4408. 10.1172\/JCI46122.","journal-title":"J Clin Invest"},{"key":"765_CR14","first-page":"33","volume":"23","author":"JR Stubbs","year":"2009","unstructured":"Stubbs JR, Quarles LD: Fibroblast growth factor 23: uremic toxin or innocent bystander in chronic kidney disease?. Nephrol News Issues. 2009, 23: 33-34. 36\u201337","journal-title":"Nephrol News Issues"},{"key":"765_CR15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M: Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005, 16: 2205-2215. 10.1681\/ASN.2005010052.","journal-title":"J Am Soc Nephrol"},{"key":"765_CR16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Bonjour JP, Rizzoli R: Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005, 90: 1519-1524. 10.1210\/jc.2004-1039.","journal-title":"J Clin Endocrinol Metab"},{"key":"765_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1210\/jc.2012-2910","volume":"98","author":"RA Kremsdorf","year":"2013","unstructured":"Kremsdorf RA, Hoofnagle AN, Kratz M, Weigle DS, Callahan HS, Purnell JQ, Horgan AM, de Boer IH, Kestenbaum BR: Effects of a high-protein diet on regulation of phosphorus homeostasis. J Clin Endocrinol Metab. 2013, 98: 1207-1213. 10.1210\/jc.2012-2910.","journal-title":"J Clin Endocrinol Metab"},{"key":"765_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moyses RM: Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?. Clin J Am Soc Nephrol. 2010, 5: 286-291. 10.2215\/CJN.05420709.","journal-title":"Clin J Am Soc Nephrol"},{"key":"765_CR19","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","volume":"26","author":"E Gonzalez-Parra","year":"2011","unstructured":"Gonzalez-Parra E, Gonzalez-Casaus ML, Galan A, Martinez-Calero A, Navas V, Rodriguez M, Ortiz A: Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients. Nephrol Dial Transplant. 2011, 26: 2567-2571. 10.1093\/ndt\/gfr144.","journal-title":"Nephrol Dial Transplant"},{"key":"765_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2215\/CJN.09250912","volume":"8","author":"T Isakova","year":"2013","unstructured":"Isakova T, Barchi-Chung A, Enfield G, Smith K, Vargas G, Houston J, Xie H, Wahl P, Schiavenato E, Dosch A, Gutierrez OM, Diego J, Lenz O, Contreras G, Mendez A, Weiner RB, Wolf M: Effects of dietary phosphate restriction and phosphate binders on FGF23 Levels in CKD. Clin J Am Soc Nephrol. 2013, 8: 1009-1018. 10.2215\/CJN.09250912.","journal-title":"Clin J Am Soc Nephrol"},{"key":"765_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2215\/CJN.07640711","volume":"7","author":"B Di Iorio","year":"2012","unstructured":"Di Iorio B, Di Micco L, Torraca S, Sirico ML, Russo L, Pota A, Mirenghi F, Russo D: Acute effects of very-low-protein diet on FGF23 levels: a randomized study. Clin J Am Soc Nephrol. 2012, 7: 581-587. 10.2215\/CJN.07640711.","journal-title":"Clin J Am Soc Nephrol"},{"key":"765_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","volume":"88","author":"CS Shinaberger","year":"2008","unstructured":"Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am J Clin Nutr. 2008, 88: 1511-1518. 10.3945\/ajcn.2008.26665.","journal-title":"Am J Clin Nutr"},{"key":"765_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","volume":"65","author":"Y Takahashi","year":"2004","unstructured":"Takahashi Y, Tanaka A, Nakamura T, Fukuwatari T, Shibata K, Shimada N, Ebihara I, Koide H: Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int. 2004, 65: 1099-1104. 10.1111\/j.1523-1755.2004.00482.x.","journal-title":"Kidney Int"},{"key":"765_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova T, Gutierrez OM, Smith K, Epstein M, Keating LK, Juppner H, Wolf M: Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant. 2011, 26: 584-591. 10.1093\/ndt\/gfq419.","journal-title":"Nephrol Dial Transplant"},{"key":"765_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470. 10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med"},{"key":"765_CR26","unstructured":"ICH harmonised tripartite guidelines for good clinical practice. 1996, \n                    http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf\n                    \n                  ,"},{"key":"765_CR27","unstructured":"Declaration of Helsinki: ethical principles for medical research involving human subjects. \n                    http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/index.html.pdf?print-media-type&footer-right=%5Bpage%5D\/%5BtoPage%5D\n                    \n                  ,"},{"key":"765_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/00365517209084290","volume":"30","author":"J Brochner-Mortensen","year":"1972","unstructured":"Brochner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972, 30: 271-274. 10.3109\/00365517209084290.","journal-title":"Scand J Clin Lab Invest"},{"key":"765_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1681\/ASN.2009121293","volume":"21","author":"M Wolf","year":"2010","unstructured":"Wolf M: Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol. 2010, 21: 1427-1435. 10.1681\/ASN.2009121293.","journal-title":"J Am Soc Nephrol"},{"key":"765_CR30","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H: Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003, 348: 1656-1663. 10.1056\/NEJMoa020881.","journal-title":"N Engl J Med"},{"key":"765_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1681\/ASN.2012030223","volume":"23","author":"GA Block","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM: Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012, 23: 1407-1415. 10.1681\/ASN.2012030223.","journal-title":"J Am Soc Nephrol"},{"key":"765_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","volume":"59","author":"MI Yilmaz","year":"2012","unstructured":"Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C: Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis. 2012, 59: 177-185. 10.1053\/j.ajkd.2011.11.007.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-15-71\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:19:09Z","timestamp":1548217149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-15-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-15-71","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,5]]},"assertion":[{"value":"15 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}